Search for other papers by Olga D. Savvidou in
Google Scholar
PubMed
Search for other papers by Panagiotis Koutsouradis in
Google Scholar
PubMed
Search for other papers by George D. Chloros in
Google Scholar
PubMed
Search for other papers by Ioannis Papanastasiou in
Google Scholar
PubMed
Search for other papers by Thomas Sarlikiotis in
Google Scholar
PubMed
Search for other papers by Aggelos Kaspiris in
Google Scholar
PubMed
Search for other papers by Panayiotis J. Papagelopoulos in
Google Scholar
PubMed
Introduction Bone tumours around the elbow are rare and their incidence is approximately 1%. 1 The literature regarding primary bone tumours of the elbow is sparse, with only two case series consisting of 75 patients and 25 patients
Search for other papers by James Plant in
Google Scholar
PubMed
Search for other papers by Stephen Cannon in
Google Scholar
PubMed
Introduction Primary bone tumours are rare, with an incidence in the United Kingdom of around six cases per million of the population. The general orthopaedic surgeon may only encounter one or two in their life’s practice. It is therefore
Search for other papers by Ajay Puri in
Google Scholar
PubMed
tumours can be quite challenging to diagnose, it is best for these lesions to be discussed in a multidisciplinary meeting which includes a radiologist and a pathologist specializing in bone tumours. Mesenchymal chondrosarcoma, an aggressive histological
Search for other papers by Antal Imre in
Google Scholar
PubMed
Search for other papers by Sápi Zoltán in
Google Scholar
PubMed
Search for other papers by Szendrői Miklós in
Google Scholar
PubMed
European Medical Agency (EMA) for GCTB under certain indications (tumours requiring morbid surgery, unresectable or metastatic GCTB). GCTB is defined by the WHO as a locally aggressive, rarely metastasising bone tumour of intermediate dignity ( 4 ). GCTB
These authors contributed equally to this manuscript
Search for other papers by Olga Savvidou in
Google Scholar
PubMed
These authors contributed equally to this manuscript
Search for other papers by Olympia Papakonstantinou in
Google Scholar
PubMed
These authors contributed equally to this manuscript
Search for other papers by Eleftheria Lakiotaki in
Google Scholar
PubMed
Search for other papers by Ioannis Zafeiris in
Google Scholar
PubMed
Search for other papers by Dimitra Melissaridou in
Google Scholar
PubMed
Co-senior authors
Search for other papers by Pinelopi Korkolopoulou in
Google Scholar
PubMed
Co-senior authors
Search for other papers by Panayiotis J. Papagelopoulos in
Google Scholar
PubMed
Introduction Surface bone tumours are neoplasms situated near the bone cortex. They are classified into five different types: osseous, cartilaginous, fibrous, lipomatous and metastatic tumours. The most common types are those producing bone
These authors contributed equally to this manuscript
Search for other papers by Olga Savvidou in
Google Scholar
PubMed
These authors contributed equally to this manuscript
Search for other papers by Olympia Papakonstantinou in
Google Scholar
PubMed
These authors contributed equally to this manuscript
Search for other papers by Eleftheria Lakiotaki in
Google Scholar
PubMed
Search for other papers by Dimitra Melissaridou in
Google Scholar
PubMed
Co-senior authors
Search for other papers by Pinelopi Korkolopoulou in
Google Scholar
PubMed
Co-senior authors
Search for other papers by Panayiotis J. Papagelopoulos in
Google Scholar
PubMed
painless bone tumour Slowly growing bone tumour, occasionally painful Swelling and/or pain, bone tumour Slowly growing soft tissue tumour +/– painful, swelling, decreased ROM Painless, enlarging palpable soft tissue tumour, decreased ROM
Search for other papers by Maria A. Smolle in
Google Scholar
PubMed
Search for other papers by Dimosthenis Andreou in
Google Scholar
PubMed
Search for other papers by Per-Ulf Tunn in
Google Scholar
PubMed
Search for other papers by Andreas Leithner in
Google Scholar
PubMed
(LDK, Co., Ltd, Haidian, Beijing, China) polypropylene mesh composite (PROLENE® light mesh, Ethicon) after bone tumour resection of the proximal humerus. 5 In that study, a mean MSTS score of 66.7% at last follow-up was reported. 5 In a
Search for other papers by Stijn E. W. Geraets in
Google Scholar
PubMed
Search for other papers by P. Koen Bos in
Google Scholar
PubMed
Search for other papers by Johan van der Stok in
Google Scholar
PubMed
Preoperative embolization of bone tumours was introduced by Feldman et al in 1975. 36 Following this report, the hypothesis that preoperative embolization of metastases reduces intraoperative blood loss was postulated by some authors during the 80s and 90s
Search for other papers by Julie J. Willeumier in
Google Scholar
PubMed
Search for other papers by Yvette M. van der Linden in
Google Scholar
PubMed
Search for other papers by Michiel A.J. van de Sande in
Google Scholar
PubMed
Search for other papers by P.D. Sander Dijkstra in
Google Scholar
PubMed
a primary bone tumour until proven otherwise. Denying this possibility might deprive patients of correct and curative treatments. If the patient has no history of malignancy, a (PET-)CT scan of the chest and abdomen should be performed. In case no
University Emergency Hospital Bucharest, Romania
Search for other papers by Catalin Cirstoiu in
Google Scholar
PubMed
University Emergency Hospital Bucharest, Romania
Search for other papers by Bogdan Cretu in
Google Scholar
PubMed
University Emergency Hospital Bucharest, Romania
Search for other papers by Bogdan Serban in
Google Scholar
PubMed
University Emergency Hospital Bucharest, Romania
Search for other papers by Zsombor Panti in
Google Scholar
PubMed
University Emergency Hospital Bucharest, Romania
Search for other papers by Mihai Nica in
Google Scholar
PubMed
-sparing surgery dominates the modern management of primary malignant bone tumours. For the reconstruction of massive bone defects resulted after the resection of bone sarcoma standard nowadays is the use of modular endoprosthetic systems, performed usually in
